Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts

Prevention of the Suicide Clinical Trial

— C-SIAM  

Official title:

Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03069560
• Other study ID #: C-SIAM (29.BRC.16.115)
• Status: Completed
• Phase: N/A
• Start date: July 19, 2017
• Est. completion date: August 8, 2019

Study information

• Verified date: May 2020
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: August 8, 2019
• Est. primary completion date: August 8, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male or female, over 18 years of age and hospitalized;

• Survivor of a suicide attempt;

• Giving informed, dated and signed consent;

• Can be reached by mobile phone. The study is proposed to all adult suicides and to the patient's designated caregiver, meeting the inclusion criteria.

Exclusion Criteria:

• Patient whose clinical condition is incompatible with the formulation of his non-opposition.

• The patient and his / her caregiver shall not be afforded a protective justice measure.

Related Conditions & MeSH terms

• Prevention of the Suicide
• Suicide
• Suicide, Attempted

Intervention

Device:
• SMS
SMS contact from the caregiver with patient after discharge in intervention group

Locations

Country	Name	City	State
France	CHU de Brest	Brest

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measurement of the feasibility of the device by the patient according to a validated questionnaire	The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.	6 months
Secondary	The questionnaire measuring the feasibility for the caregiver of such a device	A questionnaire will be provided to the caregiver to measure the feasibility of such a device	6 months
Secondary	Questionnaires on the acceptability of patients and caregivers in relation to the use of this type of monitoring device	Acceptability questionnaires will be provided to patients and caregivers in relation to the use of this type of monitoring device	6 months
Secondary	Qualitative analysis of messages sent to patients during the study.	A qualitative analysis of the messages addressed to the patients during the study will be carried out.	6 months